068270:KRX
Celltrion Inc
₩209,000.00
arrow_downward
-1.88%(-4,000.00) 1D
Nov 18, 1:32:05 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 068270...
Open
₩210,000
High
₩213,000
Low
₩208,000
Mkt. cap
48.50T
Avg. vol.
601.79K
Volume
256.14K
Dividend
0.34%
Quarterly dividend
₩178
Ex-dividend date
Dec 29, 2025
P/E ratio
30.62
52-wk high
₩239,047
52-wk low
₩158,500
EPS
₩6,842
Shares outstanding
232.13M
No. of employees
3K
Open
₩210,000
High
₩213,000
Low
₩208,000
Mkt. cap
48.50T
Avg. vol.
601.79K
Volume
256.14K
Dividend
0.34%
Quarterly dividend
₩178
Ex-dividend date
Dec 29, 2025
P/E ratio
30.62
52-wk high
₩239,047
52-wk low
₩158,500
EPS
₩6,842
Shares outstanding
232.13M
No. of employees
3K
News stories
From web sources and news partners
매일경제
·
14 minutes ago
The top 1% return on equity investment were found to have bought Celltrion, Wonik Holdings, Robotiz
파이낸셜뉴스
·
5 hours ago
Celltrion Grows Its Biosimilar Business... Targets 7 Trillion Won in Revenue Next Year
BigGo Finance
·
19 hours ago
Celltrion Rises 9% in a Month as South Korean Chip Stocks Slump, Brokerages Lift Targets
Profile
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. In 2021, Celltrion's founder, Seo Jung-jin, was the richest person in South Korea. Wikipedia
About Celltrion Inc
CEOWoosung Kee
Employees2.96K
Founded2002
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecelltrion.com